SeeTrue: The Microinjection Colored Needle For Enhanced Visibility and Anti-Clogging Capabilities
Award amount
$148,517Program and phase
SBIR · Phase IAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- SEETRUE TECHNOLOGY, LLC
- Proposal award date
- 2019-03-01
- Contract end date
- 2020-08-31
- UEI
- LJ1ZKX7C8SL5
- Solicitation number
- PA18-574
- Topic code
- 400
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- MECHANICALLY ROBUST 3D-PRINTED MICROCAPILLARY NEEDLES WITH ANTI-CLOGGING CAPABILITIES
- 3D microprinting-enabled microinjection needle arrays for enhanced therapeutics delivery into the brain
- STTR Phase I: Three-Dimensional Printing of Micro-Capillary Needle via Direct Laser Writing
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes
- Ultra-low-temperature (6 K) static NMR-DNP for metalloproteins, proteins in cells, and materials
- Dynamical Diffraction Analysis for 3D Electron Crystallography
- Synthetic biology approaches for bio-orthogonal labeling of circular RNAs
- Break Wave lithotripsy to fragment large kidney stones
Research funding history
4 SBIR/STTR records share this UEI (2019–2024). Reported award amounts total $1,073,407. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services, National Science Foundation